Oncolys BioPharma Inc.JP:4588Balance sheet

Market cap
¥67.6B
P/E ratio
2013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/122025/12
Cash and cash equivalents -4,7273,6052,5642,8682,4633,3432,0683,4551,7111,5332,4113,675
Total cash & short-term investments-4,7273,6052,5642,8682,4633,3432,0683,4551,7111,5332,4113,675
Total current assets-4,8853,6742,7473,0722,6183,8262,5464,1982,6091,9563,0984,494
Property, plant and equipment, net-5946-321221-----
Marketable securities, non-current -252483524006683290-----
Total non-current assets-12433239445581255425194428510162
Total assets -5,0094,0063,1403,5263,4304,3802,7964,2922,6512,0413,1994,556
Short-term debt-17393639383128150239228128128233
Total current liabilities-263177205239212524415430322379252471
Total non-current liabilities-37432831835531740237826817018819485
Total liabilities -637504523594529926793698492567447556
Retained earnings--5,781-6,638-7,569-8,660-9,894-10,806-12,901-14,517-1,435-3,373-5,058-2,058
Stockholders' equity5,0944,3713,5012,6172,9322,9013,4542,0033,5942,1591,4742,7524,000